Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New horizons in cancer immunotherapy: The evolving role of R848 and R837 (Review)

31 Oct 2024

Abstract excerpt

Therapeutic approaches that increase the efficacy and safety of cancer treatments and improve disease outcomes have been developed worldwide. Immunotherapy uses the body's immune system to inhibit cancerous growth in tissues and organs. Various approaches have been developed to effectively control and inhibit cancerous growth, including checkpoint inhibitors, T-cell transfer therapy, monoclonal antibodies,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immunotherapy and Immune Responses
Share to Nanoplatforms for cancer theranostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39563999
DOI: 10.3892/mco.2024.2799

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New horizons in cancer immunotherapy: The evolving role of R848 and R837 (Review)PMID 39563999Read ↗

Recent Findings on the Application of Toll-like Receptors Agonists in Cancer TherapySemantic proximity Read ↗

TLR4 exhibits a Pivotal Role in Immuno-Oncology through Systematic Pan-Cancer AnalysisSemantic proximity Read ↗

Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.Semantic proximity Read ↗

The role of toll‐like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?Semantic proximity Read ↗

Advances in cancer immunotherapy: historical perspectives, current developments, and future directionsSemantic proximity Read ↗

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious DiseasesSemantic proximity Read ↗

Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, other than Abscopal Effect: A Systematic ReviewSemantic proximity Read ↗

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?Semantic proximity Read ↗

Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer TherapeuticsSemantic proximity Read ↗

Revolutionizing Cancer Therapy: A Comprehensive Review of Immune Checkpoint InhibitorsSemantic proximity Read ↗

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).Semantic proximity Read ↗

Cancer management in the era of immunotherapy: much more than meets the eye.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.